Comment on ‘Clinical significance of BRAF non-V600E mutations on the therapeutic effects of anti-EGFR monoclonal antibody treatment in patients with pretreated metastatic colorectal cancer: the Biomarker Research for anti-EGFR monoclonal Antibodies by Comprehensive Cancer genomics (BREAC) study’

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of cancer 2018-05, Vol.118 (9), p.1276-1277
Hauptverfasser:	Dankner, Matthew, Rose, April A. N.
Format:	Artikel
Sprache:	eng
Schlagworte:	692/4028/67/1059/602 692/4028/67/1504/1885/1393 Biomedical and Life Sciences Biomedicine Cancer Research Clinical significance Colorectal carcinoma Correspondence Drug Resistance Epidemiology Epidermal growth factor receptors Metastases Molecular Medicine Monoclonal antibodies Oncology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!